Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Calabadions: New Broad-Spectrum Agents to Reverse Neuromuscular Blockade

Buscar en contenido

Contenido:

lunes, 18 de julio de 2016

ATACH-2: BP lowering in ACH

atach-2-twitter-image
The Bottom Line - July 15, 2016 - By Adrian Wong
Qureshi et al. NEJM 2016 DOI: 10.1056/NEJMoa1603460
"Clinical Question
In patients with acute intracerebral haemorrhage and who are hypertensive, does rapid lowering of systolic blood pressure compared to standard therapy improve patient outcomes ?
Authors’ Conclusions
The results of the trial do not support the reduction of systolic blood pressure to a target of 110 to 139 mmHg in patients with intracerebral haemorrhage.
The Bottom Line
The results of this trial and that of the INTERACT2 trial do not support an early, intensive control of systolic blood pressure in patients with acute intracranial haemorrhage"